Full Text View
Tabular View
No Study Results Posted
Related Studies
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
This study has been completed.
Study NCT00234858   Information provided by Abbott

First Received on September 13, 2005.   Last Updated on July 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Metabolic Syndrome
Additional conditions recognized in this trial
Metabolic Syndrome X
More general conditions related to this trial
Cardiovascular Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
trandolapril/verapamil
Additional drug interventions recognized in this trial
Diltiazem
Hydrochlorothiazide
Losartan
Trandolapril
Verapamil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services